These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2852999)

  • 101. Neuroleptic binding to sigma receptors: possible involvement in neuroleptic-induced acute dystonia.
    Jeanjean AP; Laterre EC; Maloteaux JM
    Biol Psychiatry; 1997 May; 41(10):1010-9. PubMed ID: 9129781
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Sigma receptors. Putative links between nervous, endocrine and immune systems.
    Su TP
    Eur J Biochem; 1991 Sep; 200(3):633-42. PubMed ID: 1655424
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The psychotomimetic effects of opiates and the sigma receptor.
    Musacchio JM
    Neuropsychopharmacology; 1990 Jun; 3(3):191-200. PubMed ID: 2163646
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Drugs acting on sigma and phencyclidine receptors: a review of their nature, function, and possible therapeutic importance.
    Junien JL; Leonard BE
    Clin Neuropharmacol; 1989 Oct; 12(5):353-74. PubMed ID: 2558790
    [No Abstract]   [Full Text] [Related]  

  • 105. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action.
    Sonders MS; Keana JF; Weber E
    Trends Neurosci; 1988 Jan; 11(1):37-40. PubMed ID: 2469154
    [No Abstract]   [Full Text] [Related]  

  • 106. Multiple opioid receptor systems in brain and spinal cord: Part 2.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Sep; 1(3):201-43. PubMed ID: 6152614
    [No Abstract]   [Full Text] [Related]  

  • 107. Steroid binding at sigma receptors: CNS and immunological implications.
    Su TP; Shukla K; Gund T
    Ciba Found Symp; 1990; 153():107-13; discussion 113-6. PubMed ID: 1963396
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.
    Schmauss C; Emrich HM
    Biol Psychiatry; 1985 Nov; 20(11):1211-31. PubMed ID: 2996642
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Opiate receptors].
    Latasch L; Christ R
    Anaesthesist; 1986 Feb; 35(2):55-65. PubMed ID: 2870660
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The sigma receptor and movement disorders.
    Jansen KL
    Clin Neuropharmacol; 1988 Dec; 11(6):565. PubMed ID: 2852999
    [No Abstract]   [Full Text] [Related]  

  • 111. [Pathophysiology and therapy of L-Dopa-induced dyskinesia].
    Hadj Tahar A; Bézard E; Grondin R; Gross CE; Bédard PJ
    Rev Neurol (Paris); 2003 Dec; 159(12):1125-42. PubMed ID: 14978413
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Dextromethorphan sites, sigma receptors, and the psychotomimetic effects of sigma opiates.
    Musacchio JM; Klein M; Canoll PD
    Prog Clin Biol Res; 1990; 328():13-6. PubMed ID: 2154766
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Multiple receptor types in opioid discrimination.
    Holtzman SG
    NIDA Res Monogr; 1986; 71():109-26. PubMed ID: 3025731
    [No Abstract]   [Full Text] [Related]  

  • 114. Sigma receptors: biology and function.
    Walker JM; Bowen WD; Walker FO; Matsumoto RR; De Costa B; Rice KC
    Pharmacol Rev; 1990 Dec; 42(4):355-402. PubMed ID: 1964225
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 6.